Showing results (31-40 of 149) with videos related to
Sort By:
Pageof 15
Anticancer Research|August 5, 2010
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulationPo-Han Lin, Yen-Shen Lu, Ching-Hung Lin, et al.Human Pathology|May 14, 2013
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significanceHuang-Chun Lien, Chung-Chieh Wang, Ching-Hung Lin, et al.Journal of Magnetic Resonance Imaging : JMRI|April 16, 2015
Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficientLi-An Wu, Ruey-Feng Chang, Chiun-Sheng Huang, et al.Analytica Chimica Acta|April 8, 2018
Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MSHuai-Hsuan Chiu, Hsiao-Wei Liao, Yu-Yun Shao, et al.Clinical and Translational Science|December 31, 2020
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsTomomi Hata, Kenichi Nakamura, Kan Yonemori, et al.Breast Cancer Research and Treatment|September 22, 2014
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifenTom Wei-Wu Chen, Ho-Min Chen, Ching-Hung Lin, et al.Virchows Archiv : an International Journal of Pathology|October 22, 2020
Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic componentsHuang-Chun Lien, Yi-Hsuang Lee, I-Chun Chen, et al.Cancer|November 2, 2002
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinomaChiun Hsu, Chiun-Sheng Huang, Tsu-Yi Chao, et al.Anticancer Research|January 30, 2003
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilChih-Hung Hsu, Ann-Lii Cheng, Chiun Hsu, et al.Oncology|August 10, 2005
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancerKun-Huei Yeh, Yen-Shen Lu, Chih-Hung Hsu, et al.Pageof 15